HomeCompareARRJF vs DIVO

ARRJF vs DIVO: Dividend Comparison 2026

ARRJF yields 3.38% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARRJF wins by $161.0K in total portfolio value· pulled ahead in Year 3
10 years
ARRJF
ARRJF
● Live price
3.38%
Share price
$2.97
Annual div
$0.10
5Y div CAGR
46.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$191.7K
Annual income
$83,455.04
Full ARRJF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — ARRJF vs DIVO

📍 ARRJF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARRJFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARRJF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARRJF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARRJF
Annual income on $10K today (after 15% tax)
$286.94/yr
After 10yr DRIP, annual income (after tax)
$70,936.78/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, ARRJF beats the other by $70,102.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARRJF + DIVO for your $10,000?

ARRJF: 50%DIVO: 50%
100% DIVO50/50100% ARRJF
Portfolio after 10yr
$111.2K
Annual income
$42,218.36/yr
Blended yield
37.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARRJF right now

ARRJF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
2.3
Piotroski
6/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARRJF buys
0
DIVO buys
0
No recent congressional trades found for ARRJF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARRJFDIVO
Forward yield3.38%6.49%
Annual dividend / share$0.10$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.3%0%
Portfolio after 10y$191.7K$30.7K
Annual income after 10y$83,455.04$981.68
Total dividends collected$159.4K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ARRJF vs DIVO ($10,000, DRIP)

YearARRJF PortfolioARRJF Income/yrDIVO PortfolioDIVO Income/yrGap
1$11,194$493.87$11,349$649.42$155.00DIVO
2$12,733$755.88$12,833$688.83$100.00DIVO
3← crossover$14,800$1,175.64$14,459$727.90+$341.00ARRJF
4$17,705$1,868.37$16,238$766.49+$1.5KARRJF
5$22,000$3,055.91$18,179$804.47+$3.8KARRJF
6$28,732$5,191.99$20,293$841.71+$8.4KARRJF
7$40,014$9,271.24$22,591$878.14+$17.4KARRJF
8$60,470$17,654.28$25,087$913.65+$35.4KARRJF
9$101,181$36,478.09$27,791$948.18+$73.4KARRJF
10$191,718$83,455.04$30,718$981.68+$161.0KARRJF

ARRJF vs DIVO: Complete Analysis 2026

ARRJFStock

Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.

Full ARRJF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this ARRJF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARRJF vs SCHDARRJF vs JEPIARRJF vs OARRJF vs KOARRJF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.